Literature DB >> 21175182

Fluorescent-responsive synthetic C1b domains of protein kinase Cδ as reporters of specific high-affinity ligand binding.

Nami Ohashi1, Wataru Nomura, Tetsuo Narumi, Nancy E Lewin, Kyoko Itotani, Peter M Blumberg, Hirokazu Tamamura.   

Abstract

Protein kinase C (PKC) is a critical cell signaling pathway involved in many disorders such as cancer and Alzheimer-type dementia. To date, evaluation of PKC ligand binding affinity has been performed by competitive studies against radiolabeled probes that are problematic for high-throughput screening. In the present study, we have developed a fluorescent-based binding assay system for identifying ligands that target the PKC ligand binding domain (C1 domain). An environmentally sensitive fluorescent dye (solvatochromic fluorophore), which has been used in multiple applications to assess protein-binding interactions, was inserted in proximity to the binding pocket of a novel PKCδ C1b domain. These resultant fluorescent-labeled δC1b domain analogues underwent a significant change in fluorescent intensity upon ligand binding, and we further demonstrate that the fluorescent δC1b domain analogues can be used to evaluate ligand binding affinity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21175182      PMCID: PMC3076627          DOI: 10.1021/bc100414a

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  24 in total

1.  Mechanical stress-activated PKCdelta regulates smooth muscle cell migration.

Authors:  Chaohong Li; Florian Wernig; Michael Leitges; Yanhua Hu; Qingbo Xu
Journal:  FASEB J       Date:  2003-09-04       Impact factor: 5.191

2.  Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies.

Authors:  T Watanabe; Y Ono; Y Taniyama; K Hazama; K Igarashi; K Ogita; U Kikkawa; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 3.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

4.  A new fluorescent biosensor for inositol trisphosphate.

Authors:  Takashi Morii; Kenji Sugimoto; Keisuke Makino; Masami Otsuka; Keiji Imoto; Yasuo Mori
Journal:  J Am Chem Soc       Date:  2002-02-20       Impact factor: 15.419

Review 5.  Fluoroimmunoassay: present status and key problems.

Authors:  E Soini; I Hemmilä
Journal:  Clin Chem       Date:  1979-03       Impact factor: 8.327

6.  Construction of alpha-helix peptides with beta-cyclodextrin and dansyl units and their conformational and molecular sensing properties.

Authors:  S Matsumura; S Sakamoto; A Ueno; H Mihara
Journal:  Chemistry       Date:  2000-05-15       Impact factor: 5.236

Review 7.  Prospects for targeting protein kinase C isozymes in the therapy of drug-resistant cancer--an evolving story.

Authors:  C A O'Brian; N E Ward; J R Stewart; F Chu
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

8.  Conformationally constrained analogues of diacylglycerol. 20. The search for an elusive binding site on protein kinase C through relocation of the carbonyl pharmacophore along the sn-1 side chain of 1,2-diacylglycerol lactones.

Authors:  Hirokazu Tamamura; Dina M Sigano; Nancy E Lewin; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

9.  Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C).

Authors:  Hirokazu Tamamura; Dina M Sigano; Nancy E Lewin; Megan L Peach; Marc C Nicklaus; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2004-09-23       Impact factor: 7.446

Review 10.  Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C).

Authors:  Victor E Marquez; Peter M Blumberg
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.